REGAIN STUDY: Retrospective Study to Assess the Effectiveness, Tolerability, and Safety of Ferric Carboxymaltose in the Management of Iron Deficiency Anemia in Pregnant Women

Table 3

Mean change of hemoglobin from pre- to postinfusion by FCM doses.

FCM dose (mg)	Mean	N	Std. deviation	Std. error mean	value
500
Preinfusion	9.91	142	0.53	0.04
Postinfusion	11.40	142	0.95	0.08	<0.0001
1000
Preinfusion	9.42	704	0.83	0.03
Postinfusion	11.12	704	1.04	0.03	<0.0001
1500
Preinfusion	8.76	155	0.63	0.05
Postinfusion	11.10	155	0.97	0.07	<0.0001